Risk score based on ten lncRNA-mRNA expression predicts the survival of stage II-III colorectal carcinoma

The prognosis of colorectal carcinoma (CRC) is unstable in the stage II-III patients. Patients with early stage II CRC have a relative poor prognosis while other stage III CRC patients have a better prognosis. In our work, by utilizing the expression of lncRNAs and mRNAs measured by microarray (GSE3...

Descripción completa

Detalles Bibliográficos
Autores principales: Diao, Ruigang, Mu, Xiaodong, Wang, Tingting, Li, Shuqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552098/
https://www.ncbi.nlm.nih.gov/pubmed/28796819
http://dx.doi.org/10.1371/journal.pone.0182908

Ejemplares similares

Ejemplares similares